Key Documents
Charles G. Prober
- Professor, Pediatrics - Infectious Diseases
- Professor, Microbiology & Immunology
Contact Information
- Clinical Offices
Medicine Specialties Clinic 730 Welch Rd 2nd Floor Palo Alto, CA 94304 Telephone Work (650) 736-7642 Fax (650) 725-8040
- Academic Offices
Personal Information Email CProber@stanford.eduNot for medical emergencies or patient use
Clinical Focus
- Infectious Diseases, Pediatric
- Pediatric Infectious Disease
Administrative Appointments
- Senior Associate Dean, Medical Education, Stanford School of Medicine , (2007– present )
- Associate Chair, Stanford University School of Medicine - Pediatrics , (2004– 2008 )
Honors and Awards
- The Harry Bain Award for Excellence in Clinical Teaching, The Hospital for Sick Children,University of Toronto (1984)
- Mayne Guest Professorship,Department of Child Health, University of Queensland, Brisbane, Australia (1989)
- National Institutes of Health, Immunologic and Infectious Diseases Academic Award, National Institutes of Health (1988-1993)
- Arthur L. Bloomfield Award for Teaching of Clinical Medicine, Stanford University School of Medicine (1989)
- Henry J. Kaiser Award for Clinical Teaching, Stanford University School of Medicine (1990)
- Henry J. Kaiser Award for Preclinical Teaching, Stanford University School of Medicine (1994)
Professional Education
- SUMC - Graduate Medical Education (1979) CA
- Board Certification: General Pediatrics, American Board of Pediatrics (1978)
- UCSF Medical Center (1977) CA
- Children's Hospital (1975) Canada
- Children's Hospital (1974) Canada
- Univ Of Manitoba (1973) Canada
- MD, University of Manitoba Medicine (1973)
Research Interests
My area of research interest is focused on the epidemiology, pathophysiology, prevention, and treatment of infections in children. Much of my research experience has focused on viral infections, especially those caused by herpes simplex virus (HSV). I have conducted a number of studies concerned with the epidemiology of HSV-2 infections in pregnant women, their partners, and neonates. Recently, I have extended these epidemiologic studies to adolescents. I have also conducted studies on the immunologic response to HSV infections, including humoral and cell mediated responses. Furthermore, I have participated in a number of studies evaluating optimal therapy of HSV infections in pregnant women and neonates and HSV vaccine protocols. My interest in antiviral therapy extends beyond HSV infections; I have been involved in a number of studies of therapy for respiratory viral and HIV infections. My interest in bacterial infections includes the evaluation of a number of antibacterial agents (Phase I-III studies). I also am interested in the evaluation and management of infections in compromised hosts including neonates, transplant and chemotherapy recipients. I also am interested in developing interventions to reduce the inappropriate utilization of antimicrobial agents in ambulatory and hospital environments.
I am keenly interested in medical education at the undergraduate, medical school, residency, and fellowhsip level. My educational focus has centered on microbiology and infectious diseases and on the education of clinical research scientists.
Publications
- Principles & Practice of Pediatric Infectious Diseases. 2008;
- Acta Obstet Gynecol Scand. 2007; (5): 523-9
- Clin Infect Dis. 2007; (5): 569-74
- Am J Obstet Gynecol. 2006; (1): 115-20
- N Engl J Med. 2005; (8): 753-5
- Adv Exp Med Biol. 2004; 9-12
- Pediatr Clin North Am. 2004; (4): 889-908, viii
- Herpes. 2003; (2): 32-7
- J Pediatr. 2003; (1): 4-6
- Semin Pediatr Infect Dis. 2002; (1): 31-9
- Semin Neonatol. 2002; (4): 283-91
- Pediatr Infect Dis J. 2001; (11): 1079-81
- Curr Clin Top Infect Dis. 2001; 271-301
- Pediatr Infect Dis J. 2001; (1): 90-1
- Pediatrics. 2001; (6): 1392
- Pediatrics. 2000; (6): E89
- Pediatrics. 1999; (3 Pt 1): 575
- Pediatr Infect Dis J. 1999; (8): 745-7
- J Pediatr. 1999; (5): 546-58
- Postgrad Med. 1998; (3): 123-5, 129-30, 140-3
- Pediatr Rev. 1998; (4): 118-27
- West J Med. 1997; (5): 337-8
- Pediatr Infect Dis J. 1997; (11): 1095-6
- Pediatrics. 1997; (3): 472-5
- N Engl J Med. 1997; (16): 1158-9
- Obstet Gynecol. 1997; (6): 891-5
- Semin Dermatol. 1996; (1): 8-16
- Pediatr Ann. 1996; (11): 604, 606-7
- Pediatr Infect Dis J. 1996; (4): 387-8
- Arch Pediatr Adolesc Med. 1996; (6): 632-7
- J Infect Dis. 1996; (6): 1162-7
- J Infect Dis. 1996; (5): 899-906
- Clin Pharmacokinet. 1996; (2): 156-63
- J Adolesc Health. 1996; (6): 384-6
- Pediatrics. 1995; (1): 29-31
- Curr Opin Pediatr. 1993; (1): 21-8
- Clin Obstet Gynecol. 1993; (1): 177-87
- Infect Agents Dis. 1993; (6): 375-82
- J Infect Dis. 1993; (5): 1258-9
- JAMA. 1993; (1): 77-82
- Clin Diagn Virol. 1993; (1): 29-38
- Clin Infect Dis. 1992; (6): 1031-8
- N Engl J Med. 1992; (14): 916-20
- Infect Agents Dis. 1992; (2): 99-107
- Pediatr Rev. 1992; (3): 107-12
- Pediatr Infect Dis J. 1992; (2): 156-9
- Dev Pharmacol Ther. 1992; (1-2): 71-80
- J Pediatr. 1992; (4 Pt 1): 627-33
- N Engl J Med. 1992; (13): 891; author reply 892-3
- J Infect Dis. 1992; (1): 188
- Clin Rev Allergy. 1991 Spring-Summer; (1-2): 87-102
- Am J Obstet Gynecol. 1991; (2): 569-76
- N Engl J Med. 1991; (7): 444-9
- N Engl J Med. 1991; (7): 450-4
- Pediatr Infect Dis J. 1991; (9): 684-95
- N Engl J Med. 1991; (1): 24-9
- Pediatr Infect Dis J. 1991; (1): 82-3
- Pediatr Infect Dis J. 1991; (1): 76-7
- Pediatr Infect Dis J. 1990; (2): 111-21
- Pediatr Infect Dis J. 1990; (7): 499-504
- Pediatr Infect Dis J. 1990; (8): 562-6
- J Infect Dis. 1990; (5): 1031-5
- Pediatr Infect Dis J. 1990; (12): 865-9
- Pediatr Infect Dis J. 1990; (10): 765-7
- J Infect Dis. 1989; (5): 770-6
- Curr Clin Top Infect Dis. 1989; 1-26
- Pediatr Infect Dis J. 1989; (5): 282-6
- J Infect Dis. 1988; (1): 164-71
- N Engl J Med. 1988; (14): 887-91
- J Pediatr. 1988; (3): 559-63
- Eur J Clin Microbiol. 1987; (3): 245-61
- Pediatr Infect Dis J. 1987; (3): 256-9
- N Engl J Med. 1987; (5): 240-4
- Antimicrob Agents Chemother. 1987; (1): 52-4
- Pediatr Infect Dis J. 1987; (7): 687-8
- J Pediatr Orthop. 1986 Sep-Oct; (5): 622-6
- CMAJ. 1986; (4): 328-31
- N Engl J Med. 1986; (13): 796-800
- Pediatrics. 1986; (1): 21-5
- Am J Dis Child. 1986; (5): 459-61
- Pediatr Infect Dis. 1985 Mar-Apr; (2): 211-2
- Pediatr Infect Dis. 1985 Jul-Aug; (4): 394-8
- Pediatr Infect Dis. 1985 Jan-Feb; (1): 101-3
- Can Med Assoc J. 1985; (7): 814-5
- N Engl J Med. 1985; (12): 788-9
- Clin Invest Med. 1985; (4): 368-70
- Pediatr Infect Dis. 1984 Nov-Dec; (6): 592
- Pediatr Infect Dis. 1984 Mar-Apr; (2): 110-3
- Antimicrob Agents Chemother. 1984; (1): 91-3
- N Engl J Med. 1984; (26): 1653-8
- JAMA. 1984; (9): 1174-7
- Am J Dis Child. 1984; (1): 60-3
- J Pediatr. 1984; (2): 206-10
- J Infect Dis. 1984; (2): 283
- Clin Pharmacol Ther. 1984; (3): 394-401
- Can J Public Health. 1983 Nov-Dec; (6): 409-13
- J Infect Dis. 1983; (3): 427-35
- Lancet. 1983; (8342): 158
- J Pediatr. 1983; (1): 113-4
- Clin Biochem. 1983; (3): 171-7
- Clin Pharmacol Ther. 1983; (5): 551-5
- J Antimicrob Chemother. 1983; (4): 385-9
- Pediatr Pharmacol (New York). 1983; (2): 125-6
- Prog Clin Biol Res. 1983; 421-5
- J Chromatogr. 1983; (2): 387-95
- Dev Pharmacol Ther. 1983; (5): 305-14
- Pediatr Infect Dis. 1982 Jan-Feb; (1): 8-10
- Can Med Assoc J. 1982; (11): 1085-90
- J Pediatr. 1982; (4): 622-5
- Pediatrics. 1982; (2): 215-8
- J Pediatr. 1982; (6): 1018-21
- J Pediatr. 1981; (2): 281-7
- J Pediatr. 1981; (4): 636-40
- Am J Dis Child. 1981; (5): 415-7
- Can Med Assoc J. 1981; (5): 458-60
- Can Med Assoc J. 1980; (1): 7-8
- Am J Clin Pathol. 1979; (6): 977-9
- Clin Pediatr (Phila). 1979; (8): 481-6
- Am J Dis Child. 1979; (6): 623-4
- J Pediatr. 1979; (1): 131-5
- Antimicrob Agents Chemother. 1979; (1): 46-8